SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

INHIBRX BIOSCIENCES - EXPECTS INITIAL PHASE 1/2 ORDASTOBART RESULTS IN NSCLC IN MID-2027

INBX

Related stories